The AI-based tool AiCE employs deep learning algorithms to distinguish signal from noise so that it can suppress disturbance while enhancing the signal, creating a new frontier for CT image reconstruction.
FREMONT, CA: Canon Medical Systems USA recently received 510(k) clearance on its Advanced Intelligent Clear-IQ Engine (AiCE) for the Aquilion Precision. The business also further expanded access to its new Deep Convolutional Neural Network (DCNN) image reconstruction technology. The tool is now available on both the Aquilion Precision and Aquilion ONE/GENESIS Edition premium CT systems. The technology employs deep learning algorithms to distinguish signal from noise so that it can suppress disturbance while enhancing the signal, creating a new frontier for CT image reconstruction.
Aquilion Precision is an ultra-high resolution CT that offers two times the resolution of conventional CT, revealing detail that is characteristically only seen in Cath labs. With AiCE, the system now facilitates clinicians to perform super-high resolution studies at amounts corresponding to standard resolution CT (with conventional hybrid iterative reconstruction methods). AiCE learns from the high-image-quality of Model-Based Iterative Reconstruction (MBIR) to restructure CT images with enhanced high contrast spatial resolution.
As a healthcare solution enterprise, Canon Medical offers a full array of diagnostic medical imaging solutions comprising CT, Ultrasound, X-Ray, and MR, across the globe. In line with its continued “Made for Life philosophy,” patients are at the heart of everything that the enterprise does. The business’s mission is to provide medical professionals with solutions, which support their efforts in committing to the wellbeing of patients globally. Additionally, Canon also aims at delivering optimum health opportunities for patients through uncompromised performance and comfort, along with safety features.
As Canon strives for precision medicine, it realizes the significance of starting with the foundation of an accurate diagnosis. The enterprise is committed to developing intelligent solutions that assist providers in generating more transparent and more holistic images to help attain better outcomes without increasing the dose. Additionally, for the enterprise, technology represents a new epoch in image reconstruction that will help offer more possibilities in improving patient care than ever before.